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Abstract
Background: The cotton boll weevil (Anthonomus grandis) is a serious insect-pest in the Americas, particularly in
Brazil. The use of chemical or biological insect control is not effective against the cotton boll weevil because of its
endophytic life style. Therefore, the use of biotechnological tools to produce insect-resistant transgenic plants
represents an important strategy to reduce the damage to cotton plants caused by the boll weevil. The present
study focuses on the identification of novel molecules that show improved toxicity against the cotton boll weevil.
In vitro directed molecular evolution through DNA shuffling and phage display screening was applied to enhance
the insecticidal activity of variants of the Cry8Ka1 protein of Bacillus thuringiensis.
Results: Bioassays carried out with A. grandis larvae revealed that the LC50 of the screened mutant Cry8Ka5 toxin
was 3.15-fold higher than the wild-type Cry8Ka1 toxin. Homology modelling of Cry8Ka1 and the Cry8Ka5 mutant
suggested that both proteins retained the typical three-domain Cry family structure. The mutated residues were
located mostly in loops and appeared unlikely to interfere with molecular stability.
Conclusions: The improved toxicity of the Cry8Ka5 mutant obtained in this study will allow the generation of a
transgenic cotton event with improved potential to control A. grandis.
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Background
Anthonomus grandis (Coleoptera: Curculionidae), com-
m o n l yk n o w na st h ec o t t o nb o l lw e e v i l ,i st h em o s t
harmful cotton-feeding insect-pest in the Americas
[1-4]. Even in cotton fields where the insect has been
considered eradicated (e.g. Mississipi State USA), the
growers must maintain a continued vigil because of the
tremendous ability of the boll weevil to return to pre-
vious controlled regions from time to time to re-infest.
Millions of dollars in insecticides were spent by growers
to have areas eradicated. In not eradicated areas, yield
losses to boll weevil exceeded until 10 percent in certain
years and the growers had to apply 8-12 boll weevil
sprays per field [5]. These repeated treatments are
necessary, because only adult boll weevils feed on tender
c o t t o nt e r m i n a l s ,o np o l l e nf r o mf l o w e rb u d sa n do n
fruits. The larvae are protected inside the boll, which
makes difficult the contact with chemical pesticides.
Recently presented during forum Brazil’ 2010/11, cotton
area production is estimated at 1.2 million of hectares
the highest since the early 1990’s [6]. However, espe-
cially in Brazil, boll weevil is considered a key pest in
cotton fields and despite of pest management and sev-
eral insecticide sprays, an efficient boll weevil control
does not exist. As an alternative to chemicals, the use of
transgenic plants resistant to A. grandis presents a
potential solution to the problem posed by insect-pests
[7]. The development of genetically modified (GM)
crops expressing Cry toxins has been widely researched
due to the toxic effect of these molecules against insect-
pests (lepidopterans, coleopterans and dipterans) and
nematodes which attack and thereby affect the produc-
tivity of crops such as cotton [8]. These toxins are
harmless to vertebrates and plants due their high
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any medium, provided the original work is properly cited.specificity to the insect target. Since 1996, several insect-
resistant GM cotton events have been used commer-
cially throughout the world, including Bollgard
®
(expressing the cry1Ac protein) and Bollgard II
®
(expressing the cry1Ac + cry2Ab p r o t e i n s )f r o mM o n -
santo, Widestrike
® (expressing the cry1Ac + cry1F pro-
teins) from Dow Agrosciences and VipCot
® (expressing
Vip3A protein) from Syngenta/Deltapines. This technol-
ogy has been used to control lepidopterans, allowing an
increase in productivity, reductions in production costs,
human intoxication and environmental damage due to a
reduction in chemical pesticide application [9]. At the
moment, however, none of the commercially available
GM cotton events are effective against the cotton boll
weevil, which is the most harmful cotton insect-pest in
Latin America. Cry proteins are included in parasporal
crystalline structures produced by Bacillus thuringiensis
during sporulation [10,11]. Several hypothesis about the
insecticidal mechanism of action of Cry toxins have
been discussed in previous studies [12,13], including the
pore formation model [8,13,14] and the signal transduc-
tion model [15]. More recently, Guo et al [16] proposed
a plausible model for the initiation of Cry toxin domain
disassembly before membrane penetration and pore for-
mation. After ingestion, the crystals are solubilised and
activated by insect midgut proteases. According to
Bravo and Soberon [8], the binding of toxins to specific
cadherin-like receptors triggers the oligomerization of
toxin monomers. Directed by an aminopeptidase-N
receptor, the oligomer is inserted into the cell mem-
brane and forms a pore. Those pores are responsible for
a net influx of ions and water, leading to disturbances in
osmotic balance, cell lysis, midgut damage and insect
death [8]. In the intracellular signalling model [15], the
binding of toxins to the cadherin-like receptor triggers
an Mg
2+-dependent cAMP signalling pathway that pro-
motes cell death. In both models, the affinity for cad-
herin receptors has been reported as the main step that
determines specificity. Mutations in those receptors
have been reported to be the cause of resistance acquisi-
tion [8]. Moreover, Broderick et al [17] suggested that
the cry toxin activity is also dependent on the microor-
ganisms of the insect midgut. Molecular strategies that
involve structural and biochemical studies of Cry toxins,
as well as the isolation and characterisation of new cry
genes, are necessary to help elucidate the mechanisms
of action of Cry toxins and also to select molecules that
have the potential for improved toxicity and specificity
[14].
In this context, DNA shuffling, as described by Stem-
mer [18] and following modifications reported by Zhao
and Arnold [19], is the most commonly used technique
to promote in vitro directed molecular evolution. In this
technique, the introduction of random mutations into
the nucleotide sequences results in a pool of mutants
f r o mw h i c hp r o t e i n sw i t hi m p r o v e df u n c t i o nc a nb e
selected. Considering the biotechnological context, this
technique has been used as a tool to generate libraries
that contain variant genes encoding engineered proteins,
which can subsequently be selected according to their
potential agricultural or pharmaceutical use [20,21]. In a
previous study reported by our group, a recombinant
toxin produced by the cry1Ia12 gene exhibited moderate
toxicity towards first instar larvae from both the lepi-
dopteran fall armyworm (Spodoptera frugiperda) (50%
mortality with 5 μg.mL
-1) and the coleopteran cotton
boll weevil (50% mortality with 230 μg. mL
-1) [22].
More recently, cry1Ia12synth (a cry1Ia12 synthetic gene
containing plant codon usage) was used in an approach
applying DNA shuffling coupled with the phage display
technique, which involves the presentation of peptide
and protein libraries on the surface of phage particles
for the facilitated selection of proteins with high affinity
and specificity for a determined target [23]. Our data
showed that this strategy was able to efficiently generate
genetic diversity, and the screening of the combinatorial
library for cry1Ia12synth variants resulted in the identifi-
cation of novel molecules with improved entomotoxicity
towards the sugarcane giant borer larvae, Telchin licus
licus (Lepidoptera: Castniidae), an activity not exhibited
by the wild-type protein encoded by the original
cry1Ia12 gene [24].
In a parallel manner, our team isolated a new gene
classified as cry8Ka1 (GenBank accession no. FJ422558)
from a Bt strain that showed moderate toxicity to the
cotton boll weevil [25]. The entomotoxicity of recombi-
nant Cry8Ka1 protein expressed in E. coli bioassayed
against A. grandis larvae was confirmed [25,4].
In the present study, the cry8Ka1 gene was used in
the combined DNA shuffling and phage display techni-
ques to create novel Cry mutant toxins with improved
activity towards the coleopteran A. grandis.A r o u n d1 0
5
Cry8Ka1 variants were generated, and the combinatorial
library and screened phage selection allowed the isola-
tion of new Cry toxins that exhibit improved toxicity
against the boll weevil insect-pest. Among the screened
Cry variants, Cry8Ka5 was selected for its high toxicity
and potential use as a biotechnology tool for the genera-
tion of transgenic cotton plants. Analyses from theoreti-
cal models created for Cry8Ka1 and Cry8Ka5 toxin and
comparison with other Cry toxin structures revealed
that essential structural features are conserved.
2. Methods
2.1 Preparation of A. grandis Brush Border Membrane
Vesicles (BBMVs)
Neonate A. grandis larvae were obtained from colonies
grown at the Embrapa Genetic Resources and
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diet [25]. The BBMVs were prepared from midguts of
boll weevil larvae by Mg/EGTA precipitation and differ-
ential centrifugation [26]. The larval midguts were
extracted and transferred to a microcentrifuge tube with
MET (300 mM mannitol, 5 mM EGTA, 17 mM Tris,
pH 7.5) containing 1 mM PMSF. Two hundred midguts
were centrifuged at 2500 × g for 5 min at 4°C, and the
pellet was washed twice with MET buffer. The concen-
tration of BBMVs proteins was determined by the Brad-
ford assay [27] using bovine serum albumin (BSA) as
the standard for the calibration curve. The aliquots were
stored to -80°C until use.
2.2 cry8Ka1 gene amplification
A cry8Ka1 g e n ew a sp r e v i o u s l yi s o l a t e db yo u rt e a m
from a collection of Bacillus thuringiensis at the
Embrapa Genetic Resources and Biotechnology [25] was
chosen for further studies because the encoded toxin
had the potential to control the cotton boll weevil (A.
grandis). First, the cry8Ka1 gene (2001 bp), correspond-
ing only to the active part of the toxin, was PCR-ampli-
fied from the original plasmid using Platinum Taq DNA
Polymerase High Fidelity (Invitrogen) and the Cry8Ka1s-
fiF (5’CCCGGCCCAGGCGGCCGACCACGCGTATC
GA 3’) and Cry8Ka1sfiR (5’CCCGGCCGGCCTGG
CCGTTCAAGGAACCGTT 3’) primers, which intro-
duced an Sfi I restriction site (underlined). The PCR
program included the following steps: a denaturation
step, consisting of 1 cycle at 95°C for 5 min; 29 cycles
consisting of a denaturation step of 40 s at 95°C; a
hybridisation step of 40 s at 45°C; an elongation step of
40 s at 72°C; and finally, a step consisting of 2 min at
72°C. The PCR amplification product was analysed by
1% agarose (w/v) gel electrophoresis, and the DNA
(approximately 2000 bp) was excised and gel-purified
using the Geneclean
® II Kit (BIO 101).
2.3 Generation of a combinatorial library using DNA
shuffling and phage display
The Sfi I-digested, PCR-amplified cry8Ka1 gene was
used as the starting material for the DNA-shuffling pro-
cedure [18,19]. First, 10 μg of the purified cry8Ka1 gene
was randomly digested in a mixture containing 70 U of
DNAse I enzyme (Invitrogen) in DNase I buffer (50 mM
Tris buffer, pH 7.6, containing 1 mM MnCl2 and 0.1
mg/mL BSA). The digestion reaction was performed at
15°C for 20 min and interrupted by the addition of 5 μL
of 0.5 M EDTA. The digestion product was analysed by
2.5% agarose (w/v) gel electrophoresis and the 30-50-bp
fragments were jointly purified using the High Pure
PCR Product Purification Kit (ROCHE). Ten microliters
of purified product were obtained by performing a PCR
without primers in a 25-μL final volume containing 2.5
μM of each dNTP, 0.5 mM MgSO4, and 2.5 U of Plati-
num
® Taq DNA Polymerase High Fidelity (Invitrogen)
in the supplied 1X buffer. A PCR program consisting of
the following steps was used: 95°C for 2 min; 43 cycles
of 95°C for 1 min; 44°C for 1 min and 72°C for 1 min
(with a 5-s increase in extension time per cycle); and 7
min at 72°C. To reassemble the variant genes, the pro-
duct of the primer-less PCR (7.6 μL) was used as tem-
plate for a second PCR using the Cry8Ka1SfiF and
Cry8Ka1SfiR primers. The PCR mixture had a final
volume of 500 μL and contained 0.2 mM of each dNTP,
2 mM MgSO4, 800 nM of each primer and 25 U of Taq
(Phoneutria)/Platinum
® Taq DNA Polymerase High
Fidelity (Invitrogen) (1:1 mixture) in the supplied 1X
Platinum Taq buffer. The conditions for the second
PCR were as follows: 2 min at 95°C; 10 cycles of 30 s at
9 5 ° C ;3 0sa t4 5 ° Ca n d1m i na t7 2 ° C ;1 4c y c l e so f3 0s
at 95°C; 30 s at 43°C and 42 s at 72°C (with a 20-s
increase per cycle); and finally, 7 min at 72°C. All
assembly reactions were performed in a Mastercycler
gradient thermocycler (Eppendorf). The amplified
shuffled product of approximately 2000 bp was analysed
on a 1% agarose (w/v) gel, the single band of approxi-
mately 2000 bp was excised and the DNA was gel-puri-
fied using the Geneclean
® II Kit (BIO 101). This
product was digested using the Sfi I enzyme, and the
variant genes (0.9 μg) were ligated into the pComb3X
phagemid (3.6 μg) [28], which was also linearised using
the Sfi I site. For a single reaction, T4 DNA ligase (Invi-
trogen) (12 U) and 5X ligase buffer were mixed to
obtain a 200μL final volume. The ligation product was
dialysed, lyophilised and dissolved in 15 μL of water and
subsequently fractionated into five aliquots. Each aliquot
(3 μL) was used to transform 60 μL of the electrocom-
petent XL1-Blue
® strain of Escherichia coli (Stratagene),
and the following procedures were carried out as first
described by Barbas III et al. [29] using the same modi-
fications that were previously reported in [24].
2.4 Selection of the Cry8Ka1 toxin variants that bind to A.
grandis BBMVs (biopanning)
The biopanning procedure for screening the combina-
torial library and selecting specific cry8Ka1 toxin var-
iants fused to phage particles was performed as
described by Barbas III et al. [29] with modifications
recently reported by Craveiro et al. [24]. At each round,
wells in microtitre plate were coated with BBMV pre-
paration (100 μg) and incubated 16 h at 4°C. After five
rounds of selection, the clones from the cycle that
exhibited the highest number of colony-forming units
(cfus) were isolated and analysed to verify the integrity
of the inserted cry8ka1 variant genes via colony PCR
using the Cry8Ka1sfiF and Cry8Ka1sfiR primers
(described above). The clones that presented amplicons
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expression of Cry8Ka1 variant proteins.
2.5 Expression of Cry8Ka (parental and variant gene
toxins) in fusion phage particles
First, the parental cry8Ka1 gene and several variants
exhibiting size integrity (approximately 2000 bp) were
expressed on the surface of M13 phage and analysed by
immunodetection (Dot blot) exactly as reported in a
previous study using the cry1Ia12 gene and variants by
Craveiro et al. [24].
2.6 Subcloning of cry8Ka1 and selected variant genes
into vectors for expression in E. coli bacteria
To confirm that toxins expressed by phage fusion exhib-
ited correct folding and activity, cry8Ka1 and cry8Ka5
variant genes were subcloned into the pET101/D TOPO
(Invitrogen) plasmid according to the manufacturer’s
instructions. The CRY8PETF (5’CACCATGCGA-
CACCTTCTACATCTG 3’)a n dC R Y 8 P E T R( 5 ’CTAA-
GAAGCGTAGTCCGGAAC 3’) primers were used to
insert recombinant sites into genes. The pET101-based
expression constructions, Cry8Ka1PET101 and Cry8-
Ka5PET01, were used to transform E. coli cells of the
BL21 (DE3) strain according to the manufacturer’s
instructions. One colony of the bacteria carrying each
construct was cultivated at 37°C in 5 mL of Luria Ber-
tani (LB) medium containing ampicillin (100 μgm L
-1)
(i.e., LB selective medium), under vigorous agitation
(200 rpm) until an OD600nm of 0.6 was reached. This
pre-inoculum suspension was used to inoculate 2 L of
fresh LB selective medium, which was agitated for 6 h
after induction by the addition of IPTG to a final con-
centration of 0.5 mM. Before induction, an aliquot of
the culture cells was collected and reserved. Typically,
cells were harvested by centrifugation (3000 × g,1 0
min), and the pellet was resuspended using 1 mL of 20
mM Tris- HCl (pH 8.0) buffer. Thereafter, the cell sus-
pension was lysed by sonication and stored at -80°C
until use. Final purification of His6X-tagged mature
Cry8Ka1 and variant toxins was performed using affinity
chromatography on 5 mL batches of Ni-NTA (QIA-
GEN) solid phase. The column equilibrium and chroma-
tography conditions were performed according to the
manufacturer’s instructions. The eluted fractions were
collected, dialysed against water and then lyophilised.
2.7 Western blotting analysis
The purified recombinant proteins were analysed using
SDS-PAGE [30]. Typically, a 12% gel was loaded with 5
μg of each expressed protein (Cry8Ka1 and its selected
mutants). After electrophoresis, the proteins in the gel
were visualised by Coomassie Blue R-250 staining. For
Western blotting, the protein samples were transferred
onto a HYBOND™-C EXTRA nitrocellulose membrane
using a Trans-blot Semi-dry Transfer Cell (BioRad
®).
The solution used to block the membrane consisted of
2% (w/v) bovine serum albumin (BSA) in TBS (5 mM
Tris-HCl, 15 mM NaCl, pH 7.5). Thereafter, the mem-
brane was incubated with anti-His-AP conjugate (Invi-
trogen
®) (1:2000 dilution in TBS) for 2 h at room
temperature. After the membrane was washed three
times using TBS-T (0.05% (v/v) Tween 20 (Sigma
®)
added to TBS), the immune reactive bands were
detected by immersing the blot according to the manu-
facturer’s instructions using an alkaline phosphatase
conjugate substrate
® kit (BioRad
®).
2.8 Quantification of the expressed toxins (ELISA)
To quantify proteins expressed by E. coli (as described
in 2.6), enzyme-linked immunosorbent assays (ELISA)
were performed using the polyclonal rabbit anti-
Cry8Ka1 antibody, which was previously produced and
purified by our team (not shown). The concentration of
purified proteins was first determined according to
Bradford method [27]. For a standard curve, a serial
dilution was performed using purified Cry8Ka1 toxin (4
ng to 0.0019 ng) in wells of a microtiter plate. The wells
of the plate were protein immobilised for 24 h at 4°C
and then blocked using a solution containing 3% (w/v)
BSA in TBS-T buffer for 4 h at room temperature. Fol-
lowing the washes, the polyclonal anti-Cry8Ka1 antibody
(diluted 1:10000 in TBS-T containing 1% BSA) was
deposited and incubated for 16 h at 4°C. After washes,
samples were incubated with anti-rabbit IgG secondary
antibody conjugated to peroxidase (Bio-Rad) (diluted
1:1000) for 2 h at room temperature. The TMB Peroxi-
dase EIA Substrate Kit
® (BioRad) was used for detection
according to the manufacturer’si n s t r u c t i o n s ,a n dt h e
reaction was stopped with 1 N H2SO4. The absorbance
was measured at 405 nm using Benchmark Plus
(BioRad). The assays were carried out in triplicate.
2.9 Bioassays of Cry8Ka1 and variants using A. grandis
larvae
To assess the toxicity of Cry8Ka1 and its variants
against neonate A. grandis larvae the bioassays were per-
formed in two different situations. In the first bioassays
for fast screening of variants indicating toxicity, fusion
phage-expressed Cry8ka1 and variants were utilized in
artificial diet (10
11 pfu mL
-1 of phage-expressed). Later
bioassays were repeated using expressed in bacteria and
purified Cry8ka1 and variants (0, 3, 6, 9 and 12 μg/mL)
showing significant toxicity in preliminary screening. In
both, bioassays were carried out in six-well cell culture
plates filled with artificial diet [18% (w/v) Agar, 2.72%
(w/v) Brewer’s yeast, 4.48% (w/v) Soybean protein,
2.72% (w/v) Wheat germ, 18% (w/v) Pharmamedia
® ,
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(w/v) Glucose, 0.9% (w/v) Nipagin, 0.05% (w/v) Mineral
salts, 0.45% (w/v) vitamin mixture] and phage-expressed
(first bioassay) or Cry8Ka1 or variants (detected in dot
blot analyses, data not shown)(second bioassay). Twelve
larvae were placed in each well and the plate was incu-
bated for seven days at 27°C (±1) with 80% relative
humidity and a 14-h photoperiod. An artificial diet con-
taining no additional Cry proteins was used as the nega-
tive control. Each treatment was carried out in triplicate
and the bioassay was repeated to until six different
dates. After seven days, the number of surviving larvae
was recorded for each treatment. Statistical analyses
were performed to compare the average percent mortal-
ities by ANOVA and Tukey’sm e a n sc o m p a r i s o na n a l y -
sis using the SigmaStat
® software vs. 3.1 (Systat Inc.,
San Jose, California, 2004). The LC50 (lethal concentra-
tion required to kill 50% of insects) obtained from
bioassays performed using bacteria-expressed proteins
was calculated by Probit analysis [31] using the Polo-Pc
software (LeOra Software).
2.10 DNA sequence analysis
The nucleotide sequences of the cry8Ka1 variant genes
encoding toxins active against A. grandis larvae (accord-
ing to bioassay analyses) were determined using a
3130xL Genetic Analyser (Applied Biosystems). To
obtain the complete nucleotide sequences, several pri-
mers were used. 1) Primers designed to determine the
N-terminal and C-terminal sequences were as follows:
PCOMBF (5’-GCTTCCGGCTCGTATGTTGTGT-3’)
and PCOMBR (5’-CGTTTGCCATCTTTTCATAAT-3’).
2) Primers designed to obtain the intermediate
sequences were as follows: Cry8INTERF (5’-CATATG
CACAAGCTGCGAATT-3’), Cry8INTERR (5’-GCTTC
CGGCTCGTATGTTGTGT-3’), Cry8ka5INTERF (5’-
AGCGGATTTGGGCAATTCAG-3’)a n dC r y 8 k a 5 I N -
TERR (5’-TAACAGCTGGAATTTGAGGA-3’). The
sequences were analysed using the BLASTn and
BLASTp algorithms [32], which are available on the
NCBI homepage http://www.ncbi.nlm.nih.gov/blast/
Blast.cgi. In order to assemble the sequenced fragments
and to identify the position of the mutated residues,
multiple sequence alignment programs were used,
including the STADEN PACKAGE (available at http://
staden.sourceforge.net/) [33] and CLUSTALW (available
at http://www2.ebi.ac.uk/clustalw/) [34].
2.11 Molecular analysis and homology modelling
Proteins showing homology to Cry8Ka1 were found in
the nr database at the National Center for Biotechnology
Information (NCBI) using BLAST with default para-
meters [32]. The resulting sequence set was aligned using
Muscle [35]. Suitable templates for Cry8Ka1 model
building were found using a FASTA search of sequences
in the Protein Data Bank [36] at the European Bioinfor-
matics Institute http://www.ebi.ac.uk/fasta33.
After manual refinement of the sequence alignment,
homology models of Cry8Ka1 (667 amino acid residues)
and mutant Cry8Ka5 (649 amino acid residues) were
created using MODELLER,V e r s i o n9 . 8[ 3 7 ] .T h e
Cry8Ea1 [16] (PDB entry 3EB7) toxin structures was
used as template for construction of the structural
model. In the final alignment, Cry8Ka1 shared 34.7%
sequence identity with the template. Default regimes of
model refinement by energy minimisation and simulated
annealing were employed. Because of the low sequence
similarity between target and template, a rigorous itera-
tive modelling protocol was adopted in which 50 models
were constructed and analysed. These models were ana-
lysed for packing and for stereochemical properties
using PROCHECK [38]. Possible misalignments were
highlighted by DOPE (Discrete Optimised Protein
Energy; a staticatical potential used to assess homology
models, running within the MODELLER environment)
peaks, and variations in alignment of these regions were
examined. When no further improvements could be
achieved, the model with the best PROCHECK and
DOPE scores was taken as the final model. Diagram-
matic representations of the structures were generated
using PyMOL 1.3 [39] (available at http://www.pymol.
org/).
3. Results
3.1 DNA shuffling and combinatorial library construction
To generate variants by applying the DNA shuffling pro-
cedure, the cry8Ka1 nucleotide sequence (2001 bp) was
PCR-amplified from the original vector and fragmented
using DNAse I. The resulting fragments in the 30-50 bp
r a n g ew e r ej o i n t l yp u r i f i ed and recombined to form
reassembled genes using two consecutive PCR progres-
sive programs. Using agarose gel electrophoresis, the
DNA shuffling product was visualised as a single band
of around 2000 bp that represented a population of
cry8Ka1 variant genes (Figure 1).
Both the DNA that contained the population of gene
variants (DNA shuffling products) and also the PCR-
amplified cry8Ka1 gene were excised from gel, purified
and then cloned into the pCOMB3X phagemid, result-
ing in pCOMBcry8Ka1 and pCOMBcry8Ka1var con-
structs. The pCOMBcry8Ka1var construct was used to
generate a combinatorial phage-display library of
cry8Ka1 variants containing 1.0 × 10
5 cfu/mL.
3.2 Screening of cry8Ka1 combinatorial library towards
BBMVs A. grandis
To select the clones expressing Cry8ka1 variants that
bind specifically to the A. grandis midgut, the phage-
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Five selection rounds were performed. The fifth round
was chosen because it yielded phage showing the highest
binding specificity to A. grandis BBMVs (Figure 2). Two
hundred randomly chosen clones from the fifth round
exhibited amplicons corresponding to the original gene
size of around 2000 bp (data not shown). The expres-
sion of the variant proteins was confirmed by dot blot
detection of the haemagglutinin (HA) epitope fused to
the variant proteins. A reaction signal was observed in
the dot blot for most of the analysed clones (data not
shown). Thirty clones that showed an expression signal
in the dot blot analyses were randomly selected for
further analysis of activity against A. grandis.
3.3. Evaluation of toxicity of the Cry variants in bioassays
To assess the LC50, neonate A. grandis larvae were incu-
bated with purified Cry8Ka1 and Cry8Ka5 toxins
expressed by the E. coli BL21 (DE3) strain (Figure 3).
Bioassays were conducted to evaluate the activity of
Cry8Ka1 variants compared to the wild-type Cry8Ka1
t o x i nw h e ni n c u b a t e dw i t hn e o n a t eA. grandis larvae.
The larvae mortality rate (Table 1) indicated no signifi-
cant difference between treatment with a diet
Figure 1 Illustration of the DNA shuffling steps. The DNA shuffling product was analyzed on 2.5% agarose gel electrophoresis. Lane M: 1Kb-
plus ladder (Invitrogen); lane 1: cry8Ka1 gene amplification containing only the region correspondent to mature toxin (Domains 1, II and III -
2001 bp); lane 2: DNAse I digestion product resulting to fragments of 50 bp; lane 3: Reassembled PCR product using as template fragments
containing 50 bp (obtained jointly and gel purified) and no primers added to reaction; lane 4: PCR amplification containing pool of variants
(around 2000 bp) to reassembled genes.
Figure 2 Biopanning screening of the cry8ka1 Phage display
combinatorial library for interactions of Cry8Ka1variants with
Brush Border Midgut Vesicles (BBMVs) from cotton boll weevil
larvae (A. grandis). The absorbance indicated in the graph shows
the phage-infected, which was related to the quantity of bacterial
colonies obtained from each round of biopanning. Based in the
data, the fifth round of biopanning was chosen as cycle of the
enrichment of recombinant phages displaying Cry8Ka1 variants
specifically bound to A. grandis BBMVs. The points of the curve
indicate the absorbance at 405 nm (reading of phage) in each
round.
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ted with M13 helper phage or a diet with no protein
supplementation (negative control) at the concentration
tested. On the other hand, two (Cry8Ka3 and Cry8Ka5)
out the thirty Cry8Ka1 variants tested had a statistically
significant effect on A. grandis compared to controls.
The analysis of variance was significant for the mortality
rates of these two variants. Based on these results, the
Cry8Ka5 toxin was selected for additional characterisa-
tion (Figure 4A). The LC50 for the recombinant
Cry8Ka5 protein was significantly lower (2.83 μg/mL)
than that of Cry8Ka1 (8.93 μg/mL) (Figure 4B and 4C),
indicating improved toxicity (three times higher) for the
novel toxin (Cry8Ka5) selected from the combinatorial
library of Cry8Ka1 variants (Figure 4C).
3.4 Structural analysis of Cry8Ka1 variant toxins
Firstly, the presence of genetic variability in the cry8Ka1
combinatorial library was determined using nucleotide
sequence analysis (data not shown) of 30 clones isolated
from the pool of variants that was obtained at the fifth
round of biopanning, which was chosen as the cycle
containing the highest enrichment of specific phage.
The selected cry8Ka5 gene (1947 bp) encoded a pro-
tein of 649 amino acid residues. Sequence comparisons
among the parental cry8Ka1 gene (2001 bp) and the
variant genes identified numerous nucleotide substitu-
tions (Figure 5). However, most of these nucleotide sub-
stitutions were silent mutations. In silico amino acid
sequence translation revealed just six changed residues
that were located in positions distributed throughout
the three typical domains of Cry toxins, using the
Cry8Ka1 and Cry8Ka5 comparison as indicated (Figure
6). One substitution was observed in domain I (R82Q;
within the a3 helix), two substitutions (Y260C and
P321A) were observed in domain II and three substitu-
tions (R508G, K538E and E594N) were observed in
domain III. In addition to residue substitution, a dele-
tion of 16 residues in the N-terminal part of the
Cry8Ka5 protein was observed, and this deletion was
responsible for the reduced size of the mutant as com-
pared to Cry8Ka1 (not shown). Additional sequence
analyses revealed that the five conserved blocks in the
primary structure that were previously defined in typical
Cry toxins [10,16,40] were retained in both the Cry8Ka1
parental molecule and the shuffled Cry8Ka5. According
Table 1 Bioassay showing larvicidal activity including
Cry8Ka1 toxin, the others toxins encoded by the seven
selected gene variants and VCSM13 Phage (as negative
control) using A. grandis larvae
Treatment N Lethality Mean (%) ± SD SEM
VCSM13 Phage (Control) 6 20.55 ± 2.50 b
1 1.02
Cry8Ka1 (Wild-type) 5 29.33 ± 5.47 a,b 2.44
Cry8Ka2 5 36.66 ± 5.77 a,b 2.58
Cry8Ka3 5 49.33 ± 6.30 a 2.81
Cry8Ka4 6 33.88 ± 11.95 a,b 4.88
Cry8Ka5 4 50.00 ± 11.54 a 5.77
Cry8Ka6 6 32.77 ± 15.22 a,b 6.21
Cry8Ka7 6 44.44 ± 19.16 a,b 7.82
Cry8Ka8 5 45.99 ± 17.50 a,b 7.82
10 μg/ml of expressed phage were used in every treatment
N, number of bioassays (12 larvae/replicate); SD, standard deviation; SEM,
Standard Error Mean.
1 Results indicated with the same letter have no statistical difference between
treatments (p < 0,05).
Figure 3 SDS-PAGE electrophoresis and Western blot analysis of Cry8Ka1 and Cry8Ka5 expressed in E. coli cells. The original and variant
recombinant Cry8K toxins were fractionated by SDS-PAGE, blotted onto a nitrocellulose membrane and probed with monoclonal Anti-His
®
antibody A) Lane 1, BenchMark™ Protein Ladder (Invitrogen); lane 2, proteins from non-induced cells (supernatant); lane 3, proteins expressed
after induction with 0.5 mM IPTG-(supernatant); lane 4 and 5, Cry8Ka5 and Cry8Ka1 recombinant toxins, respectively, purified by using affinity
chromatography as described in material and methods. B) Western immunoblot analysis. Lane 1 and 2 the arrows indicate Cry8Ka5 and
Cry8Ka1 recombinant toxins, both with approximate molecular weights of 70 kDa.
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Page 7 of 13to multiple sequence alignments (Figure 7), the Cry8Ka
toxins studied here had all of the highly conserved resi-
dues (highlighted in green colour) except for residue R,
which was substituted to S in position 271. There seems
to be no obvious functional consequence of this
substitution.
In addition, molecular homology analyses performed
using three-dimensional models constructed in this
study showed identical folding to Cry8Ka5 such that
Cry toxins were included in the group of three-domain
Cry toxins. The structural alignments using Cry8Ka1
and Cry8Ka5 protein sequences indicated the three best
results showing 34.7; 35.4 and 35.7% of identity with
Cry8Ea1 (3EB7.pdb) [16], Cry3Aa (1DLC.pdb) [41] and
Cry3Bb1 (1JI6.pdb) [42], respectively. Our proposed
model for Cry8Ka toxins was obtained from structural
alignments submitted to Modeller (as detailed in Materi-
als and Methods) and is illustrated in Figure 6. The final
C r y 8 K a 1a n dC r y 8 K a 5s t r u c t u r a lm o d e l sw e r ec h o s e n
based on similar and uniform distribution of amino
acids in a Ramachandran plot (93% favourable residues,
6.2% residues in allowed locations; 0.8% unfavourable
residues for Cry8Ka1 and 92.6% favourable residues,
6.6% residues in allowed locations; 0.8% unfavourable
residues for the shuffled Cry8Ka5) and on DOPE analy-
sis. The DOPE residue-by-residue energy profiles for the
final models (not shown) suggested that the models
were of high quality.
The Cry8Ka1 and Cry8Ka5 mutant models had the
same backbone structure and differed only in the
mutated side chains. Due to the very low sequence iden-
tity found in the N- and C-termini when compared to
the template, these regions were not modelled. As
shown in Figure 6, the Cry8Ka toxin model presents the
three conserved domains (I, II and III) typical of Cry
toxins. The positions of residues replaced in the shuf-
f l i n gp r o c e s sc a nb eb e t t e rs e e ni nF i g u r e s6 b - d ,i n
which the individual domain structures are illustrated.
All mutations are localised at the surface and exposed
to the solvent. In the Cry8Ka1 model, domain I consists
of residues 1-238, domain II contains residues 239-450
and domain III includes residues 451-594.
4. Discussion
In this work, the cry8Ka1 gene was used as a substrate
for DNA shuffling. This gene was isolated from the B.
thuringiensis S811 strain [25] and codes for a 668 resi-
due protein with the conserved three domain structural
architecture typical of Cry toxins. The Cry8Ka1 toxin
has been shown to be moderately toxic to A. grandis,
and our research focused on the molecular improve-
ment of the Cry8Ka1 toxin. The challenge was to intro-
duce changes in the primary structure and thereby
achieve improved insecticidal activity.
The combined strategy using DNA shuffling and
phage display techniques resulted in a combinatorial
library containing 10
5 variants. The efficiency of the
DNA shuffling approach to improve specificity and to
broaden the spectrum of insects controlled by Bt tox-
ins was first mentioned in experiments using the
cry1Ca gene. Screening of a cry1Ca-shuffled library for
activity against Spodoptera frugiperda revealed a Bt
toxin variant showing 3.8-fold higher LC50 when com-
pared to the wild-type. In other experiments, Cry1Ca
variants tested against S. exigua showed 6.7-fold higher
activity than wild-type Cry1Ca. In addition, the same
variants were active against both Heliothis zea and S.
exigua [20].
Figure 4 Toxicity of Cry8Ka1 (Wild-type) and Cry8Ka5 (variant)
proteins against A. grandis. A: Percentage mortality of A. grandis
larvae at 7 days after exposure to 0, 3, 6, 9 and 12 μg/mL of Cry
8Ka1 and Cry 8Ka5. B: Probit Scale plotted against logarithmically
Toxin Dilution (base 10). C:L C 50 and fiducial limits.
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Page 8 of 13Figure 5 Graphic representation indicates number of substitutions in the nucleotide sequences, distributed among the three domains
for that seven selected cry8Ka1 variants. The sequences of variants named cry8Ka2, cry8Ka3, cry8Ka4, cry8Ka 5, cry8Ka6, cry8Ka7 and cryKa8
were fully sequenced and aligned using cry8Ka1. In black color, indicate domain I, in gray color, domain II and white color, domain III. In each
variant a large number of nucleotide mutations was observed. The cry8Ka5 variant contained 578 nucleotide substitutions in total.
Figure 6 Ribbon diagrams of the Cry8Ka1 structural model produced with PyMOL [39]and indicating the positions of the amino acid
substitutions obtained in Cry8Ka5 toxin. A: The whole molecule showing the three domains (Domain I in brown color, II in blue color and III
in yellow color). Cry8Ka5 substituted residues are highlighted in magenta color. In B, Domain I, composed of eight a-helices, is shown. The
position of the R82Q mutation is indicated on helix a3 (also indicated in Fig 7). In C, the anti-parallel b-sheets of domain II, indicating two
substituted residues in Cry8Ka5 toxin: Cys and Ala in positions 260 and 321, respectively. In D, the jelly-roll b-sheets of Domain III, and the three
other mutated residues: Gly at position 508, Glu at 538 and Asn at 594.
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Page 9 of 13When screening genes for naturally occurring genetic
variability or for artificially generated variability as per-
formed in this study, the major concern is the choice of
an optimal selection system that guarantees efficient
screening of mutants containing the desired characteris-
tics. The technique of displaying molecules on the
phage surface [43-45] has been widely applied to select
antibody chains, to identify receptor ligands, to define
enzyme substrates, and to select anticoagulant activities
and proteinase inhibitors [46-49]. In addition, phage dis-
play systems have proven to be a useful tool for study-
ing toxins with binding domains such as Cry toxins
[24]. In the present study, we applied phage display
methodology using M13 filamentous phage; we chose to
couple this strategy to DNA shuffling because Cry tox-
ins are AB-type toxins, which have been shown to be
suitable targets for directed evolution [50,14]. As dis-
cussed in a previous study from our group [24], similar
studies have encountered problems with the functional-
ity of proteins displayed on M13 phage. In this study,
the bioassays using Cry8ka5 recombinant protein con-
firmed the molecule’s effectiveness and emphasised the
need to establish better conditions that would overcome
constraints to successfully express Cry protein variants
Figure 7 Multiple sequence alignment of activated Cry toxins after digestion (mature toxin) including translated Cry8Ka1 and mutant
Cry8Ka5 sequences. From top to bottom the sequences are Cry2Aa (Uniprot code: P0A377), Cry4Ba (P05519), Cry4Aa (P16480), Cry1Aa
(BAA04468), Cry 3Aa (P0A379), Cry3Bb1 (Q06117), Cry8Ea1 (NCBI accession: AAQ73470.1), Cry8Ka1 (FJ422558) e Cry8Ka5. The secondary structure
of Cry8Ka1 is indicated in the bottom line. The Cry8Ka a-helix colors match up to the same a-helix colors presented in our homology model
(Fig 6) constructed using Cry8Ea1 (PDB entry 3EB7) as template. The highly conserved boxes of Cry family are indicated by gray color and
labeled in the top line. Highly conserved residues are highlighted in green. The five replaced residues in the Cry8Ka5 sequence comparing to
Cry8Ka1 are highlighted in magenta. The numbers in the bottom line are those of the structural Cry8Ka1 model.
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Page 10 of 13with the M13 phage display system. The mortality found
from negative control in the first screening bioassays
was due the M13 phage system. The bioassays using
boll weevil artificial diet as here described represent a
routine in our researches aimed to investigate the
potential of novel molecules against boll weevil larvae.
However, it is clear that for biotechnology purpose, e.g.
production of insect-resistant plants, further tests must
be conducted using boll weevils in presence of the
genetic modified plants containing the selected variant
genes. In the present work the selected Cry8Ka5 mutant
toxin with improved activity against the insect target
had six residue substitutions distributed throughout the
three domains and a shorter N-terminal end than the
wild-type Cry8Ka1. Because the selected mutant toxin
was 3.1 times more active than the parental Cry8Ka1
toxin and 81.3 times more active than the Cry1Ia12
toxin [25], we concluded that the strategy of combining
DNA shuffling and phage display was able to effectively
select novel toxins that are more highly active against
the cotton boll weevil.
We modelled the three-dimensional structures of the
Cry8Ka1 toxin and the Cry8Ka5 mutant toxin by using
the three-dimensional crystal structure of activated
Cry8Ea1 (3EB7.pdb) toxin [16] as templates for homol-
ogy modelling. Cry8 and Cry3-type toxins are active
against a number of coleopteran pests; however,
Cry8Ea1 showed specific toxicity against Holotrichia
parallela (Scarabaeidae) [16]. Although Cry coleopteran
toxins have not been as extensively studied as Cry1A, it
has been shown that, as for Cry1A lepidopteran-specific
toxins, the pore formation activity of Cry3 toxins
depends on the formation of an oligomeric pre-pore
structure after the interaction of protoxins with BBMV
midgut cells from the Colorado potato beetle [51]. One
previously reported theory is that the helix bundle in
domain I is directly responsible for membrane penetra-
tion and pore formation after Cry toxins bind the speci-
fic receptors on the surface of the insect midgut [16]. In
support of this theory, our Cry8Ka toxin models con-
firmed the presence of a seven-helix bundle, as has been
generally described, and we also visualised the helix a2
separated in two helices (Figure 7), which is conserved
among Cry toxin structures [16]. According to previous
authors, the a2 helix break could be related to the
mobility of the lid on the helix bundle during correct
receptor recognition. At that moment, the lid compris-
ing helix a2b and loop a2b- a3 must be removed from
the top of the helix bundle to release the helical hairpin
a4-a5. Based on mutagenesis studies, the same authors
discussed the significance of the conserved Pro-41 resi-
due (residue number correspondent to primary structure
of the Cry8Ka toxins - Figure 7) in maintaining the sta-
bility of Cry8Ea1. According to a more recent model
proposed for the initiation of Cry toxin domain disas-
sembly, Pro-41 could be the key in facilitating the lid-
opening starting from a stable conformation [16]. Based
on these structural analyses, we suggest that the DNA
shuffling strategy applied here was able to generate
mutations without causing conformational changes that
could affect the stability of a new toxin. Regarding the
involvement of the domains II and III in the Cry toxin
mechanism, a combination of site-directed mutagenesis
and membrane binding studies [52] showed that the
exposed loops of domain II on Cry3A are involved in
receptor binding and that mutations can affect binding,
resulting in increased or decreased toxicity. Loop 1 and
loop 3 in domain II of Cry3A are directly involved in
receptor binding. In addition, the same authors sug-
gested that the loop III region might play a role in irre-
versible binding or membrane insertion. One of the
mutations created by the cry8Ka1 gene shuffling proce-
dure is localised in loop 3 of domain II in Cry8Ka5.
However, neither of the two mutations in domain II of
Cry8Ka5 is located in these loops.
Our results indicated that most structural features of the
highly conserved residues are present in the Cry8Ka mod-
elled structures. Given that our experiments to determine
the specific receptors for Cry8Ka1 toxins are currently in
development, the use of the molecular modelling results
to explain how differences in toxicity could be caused by
the specific residues changes is somewhat speculative. A
cDNA library constructed using intestinal material from
cotton boll weevil larvae will be used to screen receptor
proteins. We hope that studies involving receptor-toxin
interactions will allow us to elucidate the binding differ-
ences and increased toxicity related to the replaced resi-
dues in the three domains of the Cry8Ka5 mutant.
5. Conclusion
In conclusion, we have demonstrated that the strategy of
combining DNA shuffling and phage display was able to
effectively select novel toxins that are more highly active
against the cotton boll weevil. With its improved toxi-
city against the cotton boll weevil, a major cotton
insect-pest, the cry8Ka5 gene has the potential to be
used in plant transformation experiments to produce
genetically modified cotton plants that are A. grandis-
resistant. Our modelling studies show conservation of
core residues in the Cry8Ka5 toxin structure, suggesting
that the mutations altering activity should not affect
molecular stability.
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